SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-229280
Filing Date
2022-08-25
Accepted
2022-08-25 08:11:05
Documents
15
Period of Report
2022-08-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385381d8k.htm   iXBRL 8-K 30638
2 EX-1.1 d385381dex11.htm EX-1.1 199856
3 EX-5.1 d385381dex51.htm EX-5.1 10900
7 GRAPHIC g385381g0824150420437.jpg GRAPHIC 2533
  Complete submission text file 0001193125-22-229280.txt   427949

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rani-20220824.xsd EX-101.SCH 2885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20220824_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20220824_pre.xml EX-101.PRE 11278
9 EXTRACTED XBRL INSTANCE DOCUMENT d385381d8k_htm.xml XML 3369
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 221193041
SIC: 2834 Pharmaceutical Preparations